A Tiny Gene, a Big Journey: How One Student’s Rare Disorder Became a Fight for Science
A young researcher was born with one of only thirty people worldwide who share a rare genetic condition that shortens the body, curves the spine, and disrupts heart rhythm. Doctors labeled it BMP2‑related skeletal dysplasia spectrum disorder, but her cardiologist dubbed it Satz‑Jacobowitz syndrome. She affectionately calls it “Baggins disease”, noting the resemblance to characters from a beloved fantasy novel.
Early Life and Discovery
At 24, after learning of her mutation through genetic testing, she enrolled in a Ph.D. program at the University of Pennsylvania. Her goal: harness modern techniques like CRISPR to correct the faulty gene in her own cells. She planned to:
- Convert skin cells into induced pluripotent stem cells (iPSCs).
- Edit the mutation with CRISPR.
- Study how the corrected cells behave to understand disease mechanisms.
Setbacks
- Heart complications emerged just before her graduate studies began, delaying a life‑saving operation and extending hospital stays.
- Reduced federal funding under the recent administration cut NIH grants, causing many labs—including her mentors’—to close doors to new students.
- Pandemic restrictions halted experiments in her hospital‑based lab for safety, adding another pause.
- A case report of her condition was published without consent, raising concerns about data privacy.
Resilience and Future Plans
Despite these obstacles, she remains passionate. Her vision is to:
- Edit her own cells with CRISPR.
- Observe how correcting the mutation alters cellular behavior.
- Secure a lab that supports her work, even if it means relocating or shifting research focus.
She sees this journey as a long, challenging adventure—much like the heroes in her favorite stories—but she is driven by hope to help others with the same rare condition.
